Influence of genomic loci on measures of chronic kidney disease in hypertensive sibships

Journal of the American Society of Nephrology

Volumn 17, Issue 7, 2006, Pages 2048-2055

  Turner, Stephen T ^a   Kardia, Sharon L R ^b   Mosley, Thomas H ^c   Rule, Andrew D ^a   Boerwinkle, Eric ^d   De Andrade, Mariza ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE;

ADULT; AGED; ARTICLE; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME 7; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; ETHNIC GROUP; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SIBLING; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

EID: 33745864038     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005121254     Document Type: Article

References (50)

1. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 16: 180-188, 2005
2. Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd: Direct, progressive association of cardiovascular risk factors with incident proteinuria: Results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 165: 2299-2304, 2005
3. Korstanje R, DiPetrillo K: Unraveling the genetics of chronic kidney disease using animal models. Am J Physiol Renal Physiol 287: F347-F352, 2004
4. Perneger TV, Whelton PK, Klag MJ: Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Mem Med 155: 1201-1208, 1995
5. Multi-Center Genetic Study of Hypertension: The Family Blood Pressure Program (FBPP). Hypertension 39: 3-9, 2002
6. Daniels PR, Kardia SL, Hards CL, Brown CA, Hutchinson R, Boerwinkle E, Turner ST: Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med 116: 676-681, 2004
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
8. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Mem Med 141: 929-937, 2004
9. Bielinski SJ, Lynch AI, Miller MB, Weder A, Cooper R, Oberman A, Chen YD, Turner ST, Fornage M, Province M, Arnett DK: Genome-wide linkage analysis for loci affecting pulse pressure: The Family Blood Pressure Program. Hypertension 46: 1286-1293, 2005
10. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J: Blood pressure and decline in kidney function: Findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 13: 2776-2782, 2002
11. Amos C, de Andrade M, Zhu D: Comparison of multivariate tests for genetic linkage. Hum Hered 51: 133-144, 2001
12. Melton LJ 3rd: History of the Rochester Epidemiology Project. Mayo Clin Proc 71: 266-274, 1996
13. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST: Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Mem Med 164: 1313-1318, 2004
14. Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S, Province MA, Schwander KL, Arnett DK, Mellen BG: A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 42: 291-296, 2003
15. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
16. Amos C: Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet 54: 535-543, 1994
17. de Andrade M, Thiel TJ, Yu L, Amos CI: Assessing linkage on chromosome 5 using components of variance approach: Univariate versus multivariate. Genet Epidemiol 14: 773-778, 1997
18. Sobel E, Sengul H, Weeks DE: Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees. Hum Hered 52: 121-131, 2001
19. Morton NE: Significance levels in complex inheritance. Am J Hum Genet 62: 690-697, 1998
20. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, Anderson PJ, Rich SS, Freedman BI: A genome scan for diabetic nephropathy in African Americans. Kidney Int 66: 1517-1526, 2004
21. Fox CS, Yang Q, Cupples LA, Guo CY, Larson MG, Leip EP, Wilson PW, Levy D: Genomewide linkage analysis to serum creatinine GFR, and creatinine clearance in a community-based population: The Framingham Heart Study. J Am Soc Nephrol 15: 2457-2461, 2004
22. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W: Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86: 1154-1159, 2001
23. Pecoits-Filho R, Goncalves S, Barberato SH, Bignelli A, Lindholm B, Riella MC, Stenvinkel P: Impact of residual renal function on volume status in chronic renal failure. Blood Purif 22: 285-292, 2004
24. Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Despres JP, Vohl MC: The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48: 14-19, 2003
25. Mohlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, Bergmann MM, Ristow M, Hoffmann K, Pfeiffer AF: Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 89: 1885-1890, 2004
26. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W: Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85: 1334-1339, 2000
27. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL: Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88: 255-259, 2003
28. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basel A, Bartram CR, Van Der Woude FJ, Janssen B: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183, 2002
29. Atwood LD, Samollow PB, Hixson JE, Stern MP, MacCluer JW: Genome-wide linkage analysis of pulse pressure in Mexican Americans. Hypertension 37: 425-428, 2001
30. Wang Q, Rao S, Shen GQ, Li L, Moliterno DJ, Newby LK, Rogers WJ, Cannata R, Zirzow E, Elston RC, Topol EJ: Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 74: 262-271, 2004
31. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ: Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394: 284-287, 1998
32. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN: Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423: 57-60, 1998
33. Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J: Paraoxonase2 polymorphisms are associated with nephropathy in type II diabetes. Diabetologia 44: 104-107, 2001
34. Murata M, Maruyama T, Suzuki Y, Saruta T, Ikeda Y: Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in type 2 diabetes mellitus. Diabet Med 21: 837-844, 2004
35. Frishberg Y, Toledano H, Becker-Cohen R, Feigin E, Halle D: Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis. Am J Kidney Dis 36: 1253-1261, 2000
36. DeWan AT, Arnett DK, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt J: A genome scan for renal function among hypertensives: The HyperGEN study. Am J Hum Genet 68: 136-144, 2001
37. Chung KW, Ferrell RE, Ellis D, Barmada M, Moritz M, Finegold DN, Jaffe R, Vats A: African American hypertensive nephropathy maps to a new locus on chromosome 9q31-q32. Am J Hum Genet 73: 420-429, 2003
38. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: Results of novel discordant sib-pair analysis. Diabetes 47: 1164-1169, 1998
39. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 47: 821-830, 1998
40. Hunt SC, Coon H, Hasstedt SJ, Cawthon RM, Camp NJ, Wu LL, Hopkins PN: Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am J Hypertens 17: 511-515, 2004
41. Fox CS, Larson MG, Keyes MJ, Levy D, Clouse ME, Culleton B, O'Donnell CJ: Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: The Framingham Heart Study. Kidney Int 66: 2017-2021, 2004
42. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 12: 44-51, 1996
43. Freedman BI, Rich SS, Yu H, Roh BH, Bowden DW: Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int 62: 770-774, 2002
44. Hunt SC, Hasstedt SJ, Coon H, Camp NJ, Cawthon RM, Wu LL, Hopkins PN: Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat. Kidney Int 62: 1143-1148, 2002
45. Bochud M, Elston RC, Maillard M, Bovet P, Schild L, Shamlaye C, Burnier M: Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int 67: 61-69, 2005
46. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20: 516-519, 1997
47. Rule AD, Jacobsen SJ, Schwart GL, Mosley TH, Scott CG, Kardia SLR, Boerwinkle E, Turner ST: A comparison of serum creatinine based methods for identifying chronic kidney disease in community hypertensives and their siblings. Am J Hypertens 19: 608-614, 2006
48. Freedman BI: Susceptibility genes for hypertension and renal failure. J Am Soc Nephrol 14[Suppl 2]: S192-S194, 2003
49. Camp NJ, Hopkins PN, Hasstedt SJ, Coon H, Malhotra A, Cawthon RM, Hunt SC: Genome-wide multipoint parametric linkage analysis of pulse pressure in large, extended Utah pedigrees. Hypertension 42: 322-328, 2003
50. DeStefano AL, Larson MG, Mitchell GF, Benjamin EJ, Vasan RS, Li J, Corey D, Levy D: Genome-wide scan for pulse pressure in the National Heart, Lung and Blood Institute's Framingham Heart Study. Hypertension 44: 152-155, 2004